Drug intelligence / Profile preview

SAGM blood

Development stage
Unknown
Modality
Tissue Cells → Other Cell Types → Cell Therapies
Administration
Intravenous
01

Overview

SAGM blood refers to red blood cells (RBCs) that have been preserved in a Saline-Adenine-Glucose-Mannitol (SAGM) additive solution for transfusion. This solution is designed to extend the shelf life of red blood cells, typically up to 42 days, by providing essential nutrients and maintaining cellular integrity. Clinical studies have indicated that homologous SAGM blood transfusions may lead to immune compromise in patients, characterized by a reduction in NK cell activity and CD4:CD8 ratio, which can persist for several weeks post-surgery. This immune suppression has been associated with a higher incidence of post-operative nosocomial infections compared to non-transfused patients or those receiving autologous or leukocyte-depleted blood. Consequently, its use is advised to be judicious, with preference given to other blood product types when appropriate.

Other names
SAGM red blood cellsred cells in SAGMred blood cells in SAGM additive solutionSAGM-RBCs

Beyond the preview

Go deeper on SAGM blood.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SAGM blood.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call